BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10026437)

  • 21. Pancreatic endocrine dysfunction in rats not expressing the cholecystokinin-A receptor.
    Funakoshi A; Miyasaka K; Kanai S; Masuda M; Yasunami Y; Nagai T; Ikeda S; Jimi A; Kawanami T; Kono A
    Pancreas; 1996 Apr; 12(3):230-6. PubMed ID: 8830328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
    Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
    Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.
    Weinberg DS; Ruggeri B; Barber MT; Biswas S; Miknyocki S; Waldman SA
    J Clin Invest; 1997 Aug; 100(3):597-603. PubMed ID: 9239407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach.
    Reubi JC; Waser B; Läderach U; Stettler C; Friess H; Halter F; Schmassmann A
    Gastroenterology; 1997 Apr; 112(4):1197-205. PubMed ID: 9098003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors.
    Singh P; Owlia A; Espeijo R; Dai B
    J Biol Chem; 1995 Apr; 270(15):8429-38. PubMed ID: 7721737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of cholecystokinin-A receptor mRNA in pancreas and cholecystokinin-B receptor mRNA in oxyntic mucosa after porta-caval shunting in rats.
    Nylander AG; von Friesen CP; Monstein HJ; Yamada H; Chen D; Boketoft A; Håkanson R
    Pharmacol Toxicol; 1997 Mar; 80(3):147-51. PubMed ID: 9101588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCK receptor antagonist loxiglumide alters uptake of CCK in perfused liver and pancreatic acini of the rat.
    Beckh K; Göke R; Ruff W; Koop I; Arnold R; Adler G
    Digestion; 1991; 48(2):98-103. PubMed ID: 1868975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin.
    Ji B; Bi Y; Simeone D; Mortensen RM; Logsdon CD
    Gastroenterology; 2001 Dec; 121(6):1380-90. PubMed ID: 11729117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exogenous CCK and gastrin stimulate pancreatic exocrine secretion via CCK-A but also via CCK-B/gastrin receptors in the calf.
    Le Dréan G; Le Huërou-Luron I; Gestin M; Desbois C; Romé V; Bernard C; Dufresne M; Moroder L; Gully D; Chayvialle JA; Fourmy D; Guilloteau P
    Pflugers Arch; 1999 Jun; 438(1):86-93. PubMed ID: 10370091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of cholecystokinin A and cholecystokinin B/gastrin receptors in the canine upper gastrointestinal tract.
    Mantyh CR; Pappas TN; Vigna SR
    Gastroenterology; 1994 Oct; 107(4):1019-30. PubMed ID: 7926455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the CCK-C (cancer) receptor in human pancreatic cancer.
    Smith JP; Verderame MF; McLaughlin P; Martenis M; Ballard E; Zagon IS
    Int J Mol Med; 2002 Dec; 10(6):689-94. PubMed ID: 12429993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa.
    Schmitz F; Göke MN; Otte JM; Schrader H; Reimann B; Kruse ML; Siegel EG; Peters J; Herzig KH; Fölsch UR; Schmidt WE
    Regul Pept; 2001 Dec; 102(2-3):101-10. PubMed ID: 11730982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of cholecystokinin receptors on the human gallbladder.
    Tokunaga Y; Cox KL; Coleman R; Concepcion W; Nakazato P; Esquivel CO
    Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma.
    Goetze JP; Nielsen FC; Burcharth F; Rehfeld JF
    Cancer; 2000 Jun; 88(11):2487-94. PubMed ID: 10861424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurohormonal regulation of pancreatic exocrine function in rats without gene expression of the cholecystokinin-A receptor.
    Miyasaka K; Masuda M; Kawanami T; Funakoshi A
    Pancreas; 1996 Apr; 12(3):272-9. PubMed ID: 8830334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization.
    Lee YM; Beinborn M; McBride EW; Lu M; Kolakowski LF; Kopin AS
    J Biol Chem; 1993 Apr; 268(11):8164-9. PubMed ID: 7681836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer.
    Moonka R; Zhou W; Bell RH
    J Gastrointest Surg; 1999; 3(2):134-40. PubMed ID: 10457335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.